What Happened
Palomar Health, California's largest public health care district, paid $250,000 to resolve allegations that fentanyl was diverted from its Cardiac Catheterization Lab in Escondido and that the district failed to keep accurate controlled-substance records.
The case arose from a self-disclosure: Palomar Health notified the U.S. Drug Enforcement Administration that one of its employees may have diverted controlled substances. The government's ensuing investigation concluded that over a five-month period, numerous vials of fentanyl were diverted from automated medication dispensing machines located in the Cardiac Catheterization Lab, and that unused fentanyl was not properly disposed of as required.
In addition to the $250,000 payment, Palomar Health entered a memorandum of agreement with the DEA requiring it to increase security around controlled substances, implement specialized staff training, and handle controlled substances properly going forward. Federal officials credited the health system's self-reporting for helping prevent further harm.
What Went Wrong
- Unused fentanyl was not properly disposed of, leaving diverted quantities unaccounted for.
- Diversion from cath-lab dispensing machines continued undetected internally for roughly five months before being caught.
- Controlled-substance recordkeeping at the facility did not accurately track fentanyl, a core CSA compliance requirement.
How It Could Have Been Prevented
- Require witnessed destruction and documentation of unused controlled substances immediately after a procedure, rather than allowing delayed or informal disposal.
- Set automated alerts on dispensing-machine activity in procedural areas like cath labs, where high-value opioids are used routinely.
- Conduct regular internal audits of controlled-substance inventory in high-volume procedural units, not just facility-wide periodic counts.
- Continue to encourage prompt self-disclosure to DEA when internal review surfaces a possible diversion, as it can limit both patient harm and regulatory exposure.
Related Guidance
- Hospital Diversion Prevention Checklist — Self-assessment covering procedural-area dispensing controls.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators including improper waste disposal.
- Diversion Case Registry — More documented cases of hospital civil settlements over fentanyl diversion.
- Regulatory Guide — CSA recordkeeping and self-disclosure considerations for health systems.